Last reviewed · How we verify
NCT02912273
Optimizing Fall-risk Prediction in Older Adults With Cancer
trial testing Baseline Participant Assessment in Cancer in 227 participants. Completed in 9 January 2020.
9 January 2020
Quick facts
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 227 |
| Start date | 12 October 2016 |
| Primary completion | 9 January 2020 |
| Estimated completion | 9 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Baseline Participant Assessment
- Baseline Healthcare Provider Assessment
- Follow-up Participant Assessment
- Follow-up Healthcare Provider Assessment
- End-of-study Participant Assessment
- End-of-study Healthcare Provider Assessment
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
Washington University School of Medicine
Who can join
65 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.
Wildes TM, Maggiore RJ, Tew WP, Smith D, et al · · 2018 · cited 25× · PMID 29705872 · DOI 10.1007/s00520-018-4212-3
Verify or expand the search:
- PubMed search for NCT02912273
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Washington University School of Medicine trials
Trials by the same sponsor.
- NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
- NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
- NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
- NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
- NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02912273 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
- Last refreshed: 14 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02912273.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing